{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:02:21Z","timestamp":1792512141743,"version":"4.5.0"},"reference-count":16,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,25]]},"DOI":"10.20945\/2359-3997000000484","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T12:29:57Z","timestamp":1653568197000},"source":"Crossref","is-referenced-by-count":5,"title":["The role of intermittent continuous glucose monitoring in a successful outpatient transition from insulin to glibenclamide in a patient with transient neonatal diabetes"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4000-4853","authenticated-orcid":false,"given":"Arthur","family":"Lyra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3385-2870","authenticated-orcid":false,"given":"Fernanda Rodrigues","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9048-068X","authenticated-orcid":false,"given":"Regina C\u00e9lia Santiago","family":"Mois\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6202-6383","authenticated-orcid":false,"given":"Renata Maria de","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2085-5316","authenticated-orcid":false,"given":"Luis Eduardo","family":"Calliari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"key":"key20220526082951_B1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00592-011-0331-8","article-title":"Minimal incidence of neonatal\/infancy onset diabetes in Italy is 1:90,000 live births","volume":"49","author":"Iafusco","year":"2012","unstructured":"Iafusco D, Massa O, Pasquino B, Colombo C, Iughetti L, Bizzarri C, et al. Minimal incidence of neonatal\/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol. 2012;49:405-8.","journal-title":"Acta Diabetol"},{"key":"key20220526082951_B2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2213-8587(13)70059-7","article-title":"Neuropsychological dysfunction and neurodevelopmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study","volume":"1","author":"Busiah","year":"2013","unstructured":"Busiah K, Drunat S, Vaivre-Douret L, Bonnefond A, Simon A, FlechtnerI, et al. Neuropsychological dysfunction and neurodevelopmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study. Lancet Diabetes Endocrinol. 2013;1:199-207.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20220526082951_B3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-2-12","article-title":"Neonatal diabetes mellitus: a disease linked to multiple mechanisms","volume":"2","author":"Polak","year":"2007","unstructured":"Polak M, Cave H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis. 2007;2:12.","journal-title":"Orphanet J Rare Dis"},{"key":"key20220526082951_B4","article-title":"Non classic presentations of a genetic mutation typically associated with transient neonatal diabetes","volume":"2020","author":"Devaraja","year":"2020","unstructured":"Devaraja J, Elder C, Scott A. Non classic presentations of a genetic mutation typically associated with transient neonatal diabetes. Endocrinol Diabetes Metab Case Rep. 2020;2020:19-0121.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"key20220526082951_B5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/pedi.12772","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents","volume":"19","author":"Hattersley","year":"2018","unstructured":"Hattersley AT, Greeley SA, Polak M, Rubio-CabezasO, Nj\u00f8lstad PR, Mlynarski W, et al. ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2018;19:47-63.","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"key20220526082951_B6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/pedi.13041","article-title":"Neonatal diabetes due to potassium channel mutation: response to sulfonylurea according to the genotype","volume":"21","author":"Garcin","year":"2020","unstructured":"Garcin L, Mericq V, Fauret-Amsellem A, Cave H, Polak M, Beltrand J. Neonatal diabetes due to potassium channel mutation: response to sulfonylurea according to the genotype. Pediatr Diabetes. 2020;21(6):932-41.","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"key20220526082951_B7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","unstructured":"Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006;355(5):467-77.","journal-title":"N Engl J Med"},{"issue":"12","key":"key20220526082951_B8","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","unstructured":"Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631-40.","journal-title":"Diabetes Care"},{"key":"key20220526082951_B9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/DMSO.S198932","article-title":"Recent advances in neonatal diabetes","volume":"13","author":"Dahl","year":"2020","unstructured":"Dahl A, Kumar A. Recent advances in neonatal diabetes. Metab Syndr Obes. 2020;13:355-64.","journal-title":"Metab Syndr Obes"},{"issue":"7","key":"key20220526082951_B10","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2337\/db07-0043","article-title":"Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood","volume":"56","author":"Flanagan","year":"2007","unstructured":"Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, Robinson D, et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes. 2007;56(7):1930-7.","journal-title":"Diabetes"},{"key":"key20220526082951_B11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-8587(18)30106-2","article-title":"Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study","volume":"6","author":"Bowman","year":"2018","unstructured":"Bowman P, Sulen A, Barbetti F, Beltrand J, Svalastoga P, Codner E, et al. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. Lancet Diabetes Endocrinol. 2018;6:637-46.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20220526082951_B12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/pedi.12823","article-title":"Glibenclamide oral suspension: suitable and effective in patients with neonatal diabetes","volume":"20","author":"Beltrand","year":"2019","unstructured":"Beltrand J, Baptiste A, Busiah K, Bouazza N, Godot C, Boucheron A, et al. Glibenclamide oral suspension: suitable and effective in patients with neonatal diabetes. Pediatr Diabetes. 2019;20:246-54.","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"key20220526082951_B13","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1590\/S0004-27302008000800024","article-title":"Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene","volume":"52","author":"Della Manna","year":"2008","unstructured":"Della Manna TD, Battistim C, Radonsky V, Savoldelli RD, Damiani D, Kok F, et al. Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene. Arq Bras Endocrinol Metabol. 2008;52(8):1350-5.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"8","key":"key20220526082951_B14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1590\/S0004-27302010000800003","article-title":"Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene","volume":"54","author":"Vendramini","year":"2010","unstructured":"Vendramini MF, Gurgel LC, Mois\u00e9s RS. Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene. Arq Bras Endocrinol Metabol. 2010;54(8):682-4.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"8","key":"key20220526082951_B15","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-603.","journal-title":"Diabetes Care"},{"issue":"4","key":"key20220526082951_B16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00592-015-0828-7","article-title":"Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis","volume":"53","author":"Rabbone","year":"2016","unstructured":"Rabbone I, Barbetti F, Marigliano M, Bonfanti R, Piccinno E, Ortolani F, et al. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis. Acta Diabetol. 2016;53(4):559-65.","journal-title":"Acta Diabetol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T12:30:17Z","timestamp":1653568217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/the-role-of-intermittent-continuous-glucose-monitoring-in-a-successful-outpatient-transition-from-insulin-to-glibenclamide-in-a-patient-with-transient-neonatal-diabetes\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":16,"alternative-id":["10.20945\/2359-3997000000484"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000484","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]}}}